APA(7版)引用形式

Craddock, C., Versluis, J., Labopin, M., Socie, G., Huyn, A., Deconinck, E., . . . Nagler, A. (2016). Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Leukaemia (AML) in First CR: A survey from HOVON-SAKK and the acute leukaemia working party of the EBMT. American Society of Hematology.

Chicagoスタイル(17版)引用形式

Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.

MLA(9版)引用形式

Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.

警告: この引用は必ずしも正確ではありません.